Abstract
Parkinson’s disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra resulting in severe and progressive motor impairments. However, the mechanisms underlying this neuronal loss remain largely unknown. Oxidative stress and ER stress have been implicated in PD and these factors are known to activate the integrated stress response (ISR). Activating transcription factor 4 (ATF4), a key mediator of the ISR, and has been reported to induce the expression of genes involved in cellular homeostasis. However, during prolonged activation ATF4 can also induce the expression of pro-death target genes. Therefore, in the present study, we investigated the role of ATF4 in neuronal cell death in models of PD. We demonstrate that PD neurotoxins (MPP+ and 6-OHDA) and α-synuclein aggregation induced by pre-formed human alpha-synuclein fibrils (PFFs) cause sustained upregulation of ATF4 expression in mouse cortical and mesencephalic dopaminergic neurons. Furthermore, we demonstrate that PD neurotoxins induce the expression of the pro-apoptotic factors Chop, Trb3, and Puma in dopaminergic neurons in an ATF4-dependent manner. Importantly, we have determined that PD neurotoxin and α-synuclein PFF induced neuronal death is attenuated in ATF4-deficient dopaminergic neurons. Furthermore, ectopic expression of ATF4 but not transcriptionally defective ATF4ΔRK restores sensitivity of ATF4-deficient neurons to PD neurotoxins. Finally, we demonstrate that the eIF2α kinase inhibitor C16 suppresses MPP+ and 6-OHDA induced ATF4 activation and protects against PD neurotoxin induced dopaminergic neuronal death. Taken together these results indicate that ATF4 promotes dopaminergic cell death induced by PD neurotoxins and pathogenic α-synuclein aggregates and highlight the ISR factor ATF4 as a potential therapeutic target in PD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Postuma RB, Berg D, Stern M, Poewe W, Marek K, Litvan I. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–9.
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain . 1999;122:1437–48.
Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol. 1998;152:879–84.
Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate a-synuclein fibrilization. Nat Chem Biol. 2006;2:249–53.
Bove J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson’s disease. J Am Soc Exp Neurother. 2005;2:484–94.
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:1–21.
Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH. et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature . 2006;441:1162–6.
Geisler S, Holmström KM, Treis A, Skujat D, Weber SS, Fiesel FC. et al. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy. 2010;6:871–8.
Lee J-Y, Nagano Y, Taylor JP, Lim KL, Yao T-P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol. 2010;189:671–8.
Kaushik S, Cuervo AM. Proteostasis and aging. Nat Med. 2015;21:1406–15.
Spillantini GM, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. a-Synuclein in Lewy bodies. Nature 1997;388:839–40.
Michel PP, Hirsch EC, Hunot S. Understanding dopaminergic cell death pathways in Parkinson disease. Neuron. 2016;90:675–91.
Mercado G, Castillo V, Soto P, Sidhu A. ER stress and Parkinson’s disease: pathological inputs that converge into the secretory pathway. Brain Res. 2016;1648:626–32.
Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T. et al. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci. 2012;32:3306–20.
Heman-Ackah SM, Manzano R, Hoozemans JJM, Scheper W, Flynn R, Haerty W. et al. Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons. Hum Mol Genet. 2017;26:4441–50.
Holtz WA, O’Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem. 2003;278:19367–77.
Hoozemans JJM, van Haastert ES, Eikelenboom P, de Vos RAI, Rozemuller JM, Scheper W. Activation of the unfolded protein response in Parkinson’s disease. Biochem Biophys Res Commun. 2007;354:707–11.
Mercado G, Castillo V, Soto P, López N, Axten JM, Sardi SP, et al. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson’s disease. Neurobiol Dis. 2018;112:136–48.
Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson’s disease. J Neurosci. 2002;22:10690–8.
Slodzinski H, Moran LB, Michael GJ, Wang B, Novoselov S, Cheetham ME. et al. Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clin Neuropathol. 2009;28:333–43.
Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17:1374–95.
Donnelly N, Gorman AM, Gupta S, Samali A. The eIF2α kinases: their structures and functions. Cell Mol Life Sci; 2013;70:3493–511.
Lu PD, Jousse C, Marciniak SJ, Zhang Y, Novoa I, Scheuner D, et al. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J. 2004;23:169–79.
Singleton DC, Harris AL. Targeting the ATF4 pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:1189–202.
Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M. et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11:619–33.
Zinszner H, Kuroda M, Wang XZ, Batchvarova N, Lightfoot RT, Remotti H. et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998;12:982–95.
Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J. 1999;339:135–41.
Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3 a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005;24:1243–55.
Sun X, Liu J, Crary JF, Malagelada C, Sulzer D, Greene LA, et al. ATF4 protects against neuronal death in cellular parkinson’s disease models by maintaining levels of parkin. J Neurosci. 2013;33:2398–407.
Masuoka HC, Townes TM. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood . 2002;99:736–45.
Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW. et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol. 2002;158:507–17.
Gaven F, Marin P, Claeysen S. Primary culture of mouse dopaminergic neurons. J Vis Exp. 2014;91:e51751.
Volpicelli-Daley LA, Luk KC, Lee VMY. Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9:2135–46.
Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y. et al. Real-time imaging of the intracellular glutathione redox potential. Nat Methods. 2008;5:553–9.
Lou E, Fujisawa S, Morozov A, Barlas A, Romin Y, Dogan Y. et al. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. PLoS ONE. 2012;7:1–11.
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D. et al. A Third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463–71.
Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J. et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007;2:1236–47.
Przedborski S, Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson’s disease. Antioxid Redox Signal. 2005;7:685–93.
Fallon J, Matthews RT, Hyman BT, Beal MF. MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress. Exp Neurol. 1997;144:193–8.
Lotharius J, Dugan LL, O’Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci. 1999;19:1284–93.
Wimalasena K. The inherent high vulnerability of dopaminergic neurons toward mitochondrial toxins may contribute to the etiology of Parkinson’s disease. Neural Regen Res. 2016;11:246–7.
Müller J, Lips KS, Metzner L, Neubert RHH, Koepsell H, Brandsch M. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharm. 2005;70:1851–60.
Engel K, Wang J. Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharm. 2005;68:1397–407.
Mapa MST, Le VQ, Wimalasena, K. Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4’I-MPP+. PLoS ONE. 2018;13:e0197946.
Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C. et al. Puma is a dominant regulator of oxidative stress induced bax activation and neuronal apoptosis. J Neurosci. 2007;27:12989–99.
Chung Y, Lee J, Jung S, Lee Y, Cho JW, Oh YJ. Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis. Cell Death Dis. 2018;9:1189.
Aimé P, Sun X, Zareen N, Rao A, Berman Z, Volpicelli-Daley L, et al. Trib3 Is elevated in Parkinson’s disease and mediates death in Parkinson’s disease models. J Neurosci. 2015;35:10731–49.
Bernstein AI, Garrison SP, Zambetti GP, O’malley KL. 6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death. Mol Neurodegener. 2011;6:1–13.
Bernstein AI, O’Malley KL. MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death. Toxicol Lett. 2013;219:93–8.
Silva RM, Ries V, Oo TF, Yarygina O, Jackson-Lewis V, Ryu EJ. et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem. 2005;95:974–86.
Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics . 2019;19:1–11.
Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011;72:57–71.
Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4:160–4.
Wu Q, Takano H, Riddle DM, Trojanowski JQ, Coulter DA, Lee VMY. α-Synuclein (αsyn) preformed fibrils induce endogenous αsyn aggregation, compromise synaptic activity and enhance synapse loss in cultured excitatory hippocampal neurons. J Neurosci. 2019;39:5080–94.
Blumenstock S, Rodrigues EF, Peters F, Blazquez‐Llorca L, Schmidt F, Giese A, et al. Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex. EMBO Mol Med. 2017;9:716–31.
Lewerenz J, Sato H, Albrecht P, Henke N, Noack R, Methner A, et al. Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression. Cell Death Differ. 2011;19:847–58.
Lewerenz J, Maher P. Basal levels of eIF2α phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem. 2009;284:1106–15.
Lange P, Chavez J, Pinto J, Coppola G, Sun C, Townes T, et al. ATF4 is an oxidative stress—inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med. 2008;205:1227–42.
Zille M, Kumar A, Kundu N, Bourassa MW, Wong VSC, Willis D, et al. Ferroptosis in neurons and cancer cells is similar but differentially regulated by histone deacetylase inhibitors. eNeuro 2019;6:263–81.
Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, Cregan SP. Cellular/molecular neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci. 2010;30:16938–48.
Gully JC, Sergeyev VG, Bhootada Y, Mendez-Gomez H, Meyers CA, Zolotukhin S, et al. Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson’s disease. Neurosci Lett. 2016;627:36–41.
Hettmann T, Barton K, Leiden JM. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev Biol. 2000;222:110–23.
Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, et al. Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell 2014;158:1159–72.
Matus S, Lopez E, Valenzuela V, Nassif M, Hetz C. Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:1–12.
Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300:1574–7.
Ghosh AP, Klocke BJ, Ballestas ME, Roth KA. CHOP Potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS ONE. 2012;7:e39586
Saleem S, Biswas SC. Tribbles pseudokinase 3 induces both apoptosis and autophagy in amyloid-β-induced neuronal death. J Biol Chem. 2017;292:2571–85.
Ambacher KK, Pitzul KB, Karajgikar M, Hamilton A, Ferguson SS, Cregan SP. The JNK- and AKT/GSK3β-signaling pathways converge to regulate Puma Induction and neuronal apoptosis induced by trophic factor deprivation. PLoS ONE. 2012;7:1–14.
Scheper W, Hoozemans JJM. A new PERKspective on neurodegeneration. Sci Transl Med. 2013;5:1–3.
Hugon J, Mouton-Liger F, Dumurgier J, Paquet C. PKR involvement in Alzheimer’s disease. Alzheimer’s Res Ther. 2017;9:1–10.
Chen H-M, Wang L, D’Mello SR. A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur J Neurosci. 2008;28:2003–16.
He R, Huang W, Huang Y, Xu M, Song P, Huang Y, et al. Cdk5 inhibitory peptide prevents loss of dopaminergic neurons and alleviates behavioral changes in an MPTP induced Parkinson’s disease mouse model. Front Aging Neurosci. 2018;10:162.
Qu D, Rashidian J, Mount MP, Aleyasin H, Parsanejad M, Lira A, et al. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron 2007;55:37–52.
Wilkaniec A, Czapski GA, Adamczyk A. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses. J Neurochem. 2016;136:222–33.
Karuppagounder SS, Alim I, Khim SJ, Bourassa MW, Sleiman SF, John R, et al. Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models. Sci Transl Med. 2016;8:328ra29.
Aimé P, Karuppagounder SS, Rao A, Chen Y, Burke RE, Ratan RR, et al. The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson’s disease. Neurobiol Dis. 2020;136:104725.
Acknowledgements
This work was supported by grants from the Canadian Institutes of Health Research and the Heart & Stroke Foundation of Canada to SPC and an Ontario Graduate Scholarship to MDD.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by J.M. Hardwick
Supplementary information
41418_2020_688_MOESM3_ESM.tif
The eIF2α kinase inhibitor C16 attenuates PD neurotoxin induced pro-death target gene induction and apoptosis in cortical neurons.
Rights and permissions
About this article
Cite this article
Demmings, M.D., Tennyson, E.C., Petroff, G.N. et al. Activating transcription factor-4 promotes neuronal death induced by Parkinson’s disease neurotoxins and α-synuclein aggregates. Cell Death Differ 28, 1627–1643 (2021). https://doi.org/10.1038/s41418-020-00688-6
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41418-020-00688-6
This article is cited by
-
The integrated stress response in neurodegenerative diseases
Molecular Neurodegeneration (2025)
-
SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease
Acta Pharmacologica Sinica (2024)
-
Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson’s disease
Scientific Reports (2024)
-
ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer
Scientific Reports (2024)
-
17β-estradiol alleviated ferroptotic neuroinflammation by suppressing ATF4 in mouse model of Parkinson’s disease
Cell Death Discovery (2024)
